Alpha Cognition says CONVERGE real-world study shows 79.1% of ZUNVEYL users in long-term care reach therapeutic dose
Bitget2026/10/01 12:31- Alpha Cognition reported initial results from CONVERGE, an ongoing retrospective real-world evidence analysis in long-term care.
- Results have already been presented as initial findings, with additional measures to be analyzed as the dataset expands.
- ZUNVEYL users were more likely to reach therapeutic dosing than residents on generic acetylcholinesterase inhibitors, including switch patients.
- Medication burden trended lower for ZUNVEYL residents, while it rose for residents receiving pooled generic acetylcholinesterase inhibitors.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US Dollar Index slips from its 18-month high
Monnalisa shares delist from Euronext Growth Milan
Monnalisa’s delisting from trading on Euronext Growth Milan took effect today. The company is preparing a shareholder buyback process led by Modamet and Jafin Due for investors seeking to sell. Further details are due in coming days on the purchase window and a single settlement date for the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monnalisa S.p.A. published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.
ICE brings futures trading to London’s $190 billion-a-day physical gold market
Precia reports 5,733,040 issued shares, 8,350,574 exercisable voting rights as of Aug. 31, 2026
Precia disclosed 5,733,040 issued shares as of Aug. 31, 2026. Theoretical voting rights totaled 8,677,204. Exercisable voting rights stood at 8,350,574, reflecting 326,630 treasury shares without voting rights. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Precia SA published the original content used to generate this news brief on October 06, 2026, and is solely responsible for the information contained therein.
Crypto prices
More
